Pain Medication DNA Insight®
Effective Prescription for Pain Medication
CYP2D6, CYP2B6, OPRM1
The Opioid class of compounds has been extensively used to treat acute pain as well as to alleviate severe chronic pain associated with certain terminal conditions1.
Non-steroidal anti-inflammatory drugs (NSAIDs) are a class of drugs widely used for their analgesic, anti-pyretic and anti-inflammatory properties8.
Pain Medication DNA Insight® can be ordered from a licensed and registered physician or other qualified healthcare provider.
The patient will provide a saliva or blood sample using the collection kit in the Pathway Genomics box. The authorized physician will mail the sample back to Pathway Genomics, along with the test requisition and consent form (return shipping provided).
View the saliva collection instructional video here. For blood collection instructions, click here.
Pathway Genomics processes and analyzes the submitted sample in its CLIA-certified and CAP-accredited laboratory. Typically within two to three weeks, the patient’s personalized results will be available to the ordering physician. The results will then be released to the patient. Pathway Genomics has a team of genetic counselors available to ensure that both the patient and the physician understand the information in the report, and to answer additional questions. To contact a Pathway Genomics genetic counselor, please call client services department at 877-505-7374 or email email@example.com.
Pain Medication DNA Insight® is for patients currently taking, or considering taking a pain medication. This clinically-actionable genetic test can assist physicians in understanding patients’ response to certain pain medications, and can help with identification of optimal treatment plans.
Based on the individual’s unique genetic profile, Pain Medication DNA Insight® provides information that enables the physician to: